Noven is committed to developing and offering products and technologies that meaningfully benefit patients. We offer products in the areas of women’s health and mental health.

Today, Noven is the US platform for Hisamitsu, the world's largest patch manufacturer, with fully integrated R&D, clinical, manufacturing, and sales functions offering prescription products in …

COMBIPATCH ® (estradiol/norethindrone acetate transdermal system), developed and manufactured by Noven Pharmaceuticals, was the first combination (two-drug) patch approved …

Report Suspected Side Effects and/or Product Complaints Tel: 800-455-8070 Email: [email protected]

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and mental health, including ADHD and schizophrenia.

Noven's commercialized products are marketed through Noven Therapeutics, LLC. Noven’s product development pipeline includes a range of prescription transdermal products that utilize …

Today, Noven is the US platform for Hisamitsu, the world's largest patch manufacturer, with fully integrated R&D, clinical, manufacturing, and sales functions offering prescription products in …

Noven markets and sells Estradiol Transdermal System through Grove Pharmaceuticals, Noven’s authorized generic division. Click here to find the authorized generic at a pharmacy near you.

Noven’s Mission is to develop and offer pharmaceutical products that meaningfully benefit patients around the world, with a commitment to advancing patient care through transdermal …

In this area, Noven developed the first FDA-approved adhesive matrix estrogen therapy patch, the first approved combination (two-drug) patch, COMBIPATCH® (estradiol/norethindrone acetate …